Search Within

Min Yuen Teo

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (27)
  2. Journal Article (18)
  3. Editorial (1)
Groups
  1. Department of Medicine (46)
  2. Genitourinary Oncology Service (46)
  3. Human Oncology and Pathogenesis Program (46)
  4. Solid Tumor Oncology Division (46)
  5. Department of Pathology and Laboratory Medicine (42)
  6. GSK Faculty (42)

More Groups

People
  1. Gopakumar Iyer (45)
  2. David Solit (40)
  3. Dean Bajorin (40)
  4. Jonathan Rosenberg (40)
  5. Hikmat Al-Ahmadie (39)
  6. Bernard Bochner (31)

More People

Years
  1. 2025 (1)
  2. 2024 (6)
  3. 2023 (3)
  4. 2022 (9)
  5. 2021 (4)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (21)
  2. Modern Pathology (4)
  3. Cancer Research (3)
  4. Clinical Cancer Research (3)
  5. Laboratory Investigation (3)
  6. European Urology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (23)
  2. American Association for Cancer Research (6)
  3. Nature Publishing Group (5)
  4. Nature Research (4)
  5. Cell Press (2)
  6. Elsevier Science, Inc. (2)

More Publishers

Results (46)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Detection of FGFR3 alt in plasma cfDNA in metastatic UC patients receiving Erda therapy
    Meeting Abstract

    Sarfaty, M.; Teo, M. Y.; Funt, S. A.; Lee, C. H.; Aggen, D. H.; Ratna, N.; Regazzi, A. M.; Lenis, A. T.; Chen, Z.; Al-Ahmadie, H. A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Large cell neuroendocrine carcinoma of the urothelial tract (LNEC): The MSKCC experience
    Meeting Abstract

    Guercio, B. J.; Gandhi, J.; Teo, M. Y.; Lattanzi, M.; Funt, S. A.; Aggen, D. H.; Chen, Y. B.; Fine, S.; Pietzak, E. J.; Bochner, B. H.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma
    Journal Article

    Teo, M. Y.; Al-Ahmadie, H.; Seier, K.; Tully, C.; Regazzi, A. M.; Pietzak, E.; Solit, D. B.; Tickoo, S.; Reuter, V.; Cha, E. K.; more...
    British Journal of Cancer (2021)

    Fulltext@MSK | Save
  • MSK-ACCESS for the detection of fibroblast growth factor receptor-3 (FGFR3) mutations in plasma cell-free (cf)DNA of metastatic urothelial carcinoma (mUC) patients (pts) pre- and on erdafitinib (erda) therapy
    Meeting Abstract

    Sarfaty, M.; Teo, M. Y.; Funt, S. A.; Lee, C. H.; Aggen, D. H.; Ratna, N.; Regazzi, A. M.; Al-Ahmadie, H.; Brannon, A. R.; Berger, M. F.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Fibroblast growth factor receptor 3 alteration status is associated with differential sensitivity to platinum-based chemotherapy in locally advanced and metastatic urothelial carcinoma
    Journal Article

    Teo, M. Y.; Mota, J. M.; Whiting, K. A.; Li, H. A.; Funt, S. A.; Lee, C. H.; Solit, D. B.; Al-Ahmadie, H.; Milowsky, M. I.; Balar, A. V.; more...
    European Urology (2020)

    Fulltext@MSK | Save
  • Clinicogenomic predictors of extreme responses to anti-PD1/PDL1 checkpoint inhibitors (CPI) in metastatic urothelial cancer (mUC)
    Meeting Abstract

    Teo, M. Y.; Whiting, K.; Mota, J. M.; Li, H.; Regazzi, A. M.; Solit, D. B.; Aggen, D. H.; Lee, C. H.; Funt, S. A.; Bajorin, D. F.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Characterization of tumor mutational landscape in smokers and nonsmokers with urothelial carcinoma
    Meeting Abstract

    Walasek, A.; Almassi, N.; Teo, M. Y.; Funt, S.; Schultz, N.; Dalbagni, G.; Hu, W.; Al-Ahmadie, H.; Bajorin, D. F.; Rosenberg, J. E.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy
    Journal Article

    Ged, Y.; Chaim, J. L.; DiNatale, R. G.; Knezevic, A.; Kotecha, R. R.; Carlo, M. I.; Lee, C. H.; Foster, A.; Feldman, D. R.; Teo, M. Y.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Microsatellite instability (MSI-H) in metastatic urothelial carcinoma (mUC): A biomarker of divergent responses to systemic therapy
    Meeting Abstract

    Sarfaty, M.; Teo, M. Y.; Al-Ahmadie, H.; Funt, S. A.; Lee, C. H.; Aggen, D. H.; Solit, D. B.; Ratna, N.; Regazzi, A. M.; Hechtman, J. F.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Defining the genetic evolution of epigenetic alterations in bladder cancer
    Meeting Abstract

    Clinton, T. N.; Wise, H.; Almassi, N.; Chavan, S. S.; Hu, W.; Gao, S. P.; Hanrahan, A.; Dason, S.; Pietzak, E. J.; Carlo, M. I.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save